Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Vion Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the research, development and commercialization of cancer treatment technologies. Vion’s product portfolio consists of TAPET®, a drug delivery platform, and three cancer therapeutics (Promycin®, Triapine® and sulfonylhydrazine Prodrugs). TAPET has been shown in preclinical models to effectively deliver anticancer agents while having a minimal toxic effect on healthy normal tissues. TAPET uses genetically altered strains of Salmonella as a bacterial vector, or vehicle, for delivering cancer fighting drugs preferentially to solid tumors. Promycin, which attacks oxygen depleted cancer cells, is currently being evaluated with radiation in a multicenter Phase III clinical trial for the treatment of head and neck cancer. ( www.vionpharm.com )
Vion Pharmaceuticals , Inc.
Four Science Park
New Haven, Connecticut 06511
USA
Tel: (203) 498-4210
Fax: (203) 498-4211